Source: International Congress 2014 – ILDs 3
Disease area: Interstitial lung diseases

Abstract

Interstitial lung diseases (ILDs) are characterized by a chronic and progressive course with reduced quality of life (QoL). Depressive symptoms are common and persistent in patients with ILD.Mindfulness-based stress reduction (MBSR) is a protocol integrating Buddhist meditation with contemporary clinical and psychological practice; MBSR has already proven to reduce negative moods related to chronic symptoms.Nineteen ILD patients (M=11, mean age ± SD: 65 ± 8 years; 12 affected by idiopathic pulmonary fibrosis) were enrolled in a prospective, open-label, observational study evaluating feasibility, safety, and effect on QoL and lung function of a MBSR program. The intervention consisted of 8 weekly group meetings and 45 minutes-long daily home training. Three quarterly group meetings were added in the follow-up. Outcomes included change in Shortness Of Breath Questionnaire (SOB), Cough And Sputum Assessment Questionnaire (CASA-Q), Profile Of Mood State (POMS) test, Perceived Stress Scale (PSS), pulmonary function tests and 6-minutes walking test between enrolment, end of intervention and end of 1-year follow-up.Two patients (10.5%) dropped out early for non-respiratory causes (low back pain and chronic fatigue, respectively). Adherence to the program was 89%. A statistically significant reduction in POMS total score and in the "rage" and "irritability" components of the PSS test was observed (p<0.05). Other questionnaire scores and pulmonary function parameters did not show significant change over time.These results suggest that a MBSR program is feasible and safe in ILD patients. The observed reduction in negative moods lends support to the design of confirmatory larger controlled trials.

Rating:

Share or cite this content

Citations should be made in the following way:
G. Sgalla, R. Ferrari, S. Cerri, M. P. Ricchieri, M. Ori, M. Garuti, G. Montanari, S. Taddei, F. Luppi, R. Luca (Southampton, United Kingdom; Bologna, Modena, Italy). Mindfulness-based stress reduction in patients with interstitial lung disease: A pilot study. Eur Respir J 2014; 44: Suppl. 58, 777

Member's Comments

No comment yet.

Related content which might interest you: Does CRP predicts severity of hospitalized patients with diffuse interstitial lung disease? Source: International Congress 2014 – ILDs 5 Year: 2014 Pregnancy course in patients with interstitial lung diseases Source: International Congress 2014 – ILDs 5 Year: 2014 Does hypoxemia increases risks in hospitalized patients with diffuse interstitial lung disease? Source: International Congress 2014 – ILDs 6 Year: 2014 Evolution of an interstitial lung disease MDT: 5.5 years of data Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Beneficial effect of azithromycin in children with diffuse parenchymal lung disease Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Treatment of IPF with inhaled IFN-gamma; planning for a clinical trial Source: International Congress 2014 – ILDs 3 Year: 2014 The role of CCR2+CD4+T cells in lung fibrosis Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Lymphangioleiomyomatosis in TOSCA - TuberOus SClerosis registry to increAse disease awareness Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Clinical effect of pirfenidone on incidence of lung carcinoma in chronic interstitial pneumonia Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Aetiological panorama in the diagnosis of interstitial lung diseases Source: International Congress 2014 – ILDs 5 Year: 2014 Desquamative interstitial pneumonia in a Danish cohort, treatment response and outcome Source: International Congress 2014 – ILDs 2 Year: 2014 Live patient and partner survey on pulmonary fibrosis Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Pulmonary manifestations in rheumatoid arthritis: A hospital based descriptive study Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Acute exacerbation of idiopathic pulmonary fibrosis: Analysis in a post-marketing surveillance of pirfenidone Source: International Congress 2014 – Clinical trials in IPF Year: 2014 Six-minute-walk test parameters in the prognostic evaluation of fibrotic lung diseases Source: International Congress 2014 – ILDs 4 Year: 2014 Cystic lung disease with pulmonary amyloidosis: Analysis of 21 patients Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Clinical course and outcome of vasculitis related interstitial lung disease Source: International Congress 2014 – ILDs 2 Year: 2014 Clinical data, lung function and cardiopulmonary exercise testing in CPFE (combined pulmonary fibrosis with emphysema). Results of a cohort of 20 patients Source: International Congress 2014 – ILDs 6 Year: 2014 LATE-BREAKING ABSTRACT: Current management of patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry Source: International Congress 2014 – Clinical trials in IPF Year: 2014 "Cyclophosphamide for the treatment of inflammation driven fibrotic interstitial lung disease" Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014